By Josh White
Date: Friday 21 Feb 2025
(Sharecast News) - Proteome Sciences announced on Friday that it has secured a contract worth over $1m from a US biopharmaceutical company for the use of its mass spectrometry services in an ongoing clinical trial.
By Benjamin Chiou
Date: Monday 23 Dec 2024
(Sharecast News) - Shares in drug development services group Proteome Sciences rose on Monday after the company said 2024 results should reflect a good recovery and that its pipeline is looking strong for next year.
By Josh White
Date: Friday 13 Sep 2024
(Sharecast News) - Proteome Sciences announced a significant drop in first-half revenue and profit on Friday, alongside the departure of its chief executive.
| Currency | UK Pounds |
| Share Price | 1.96p |
| Change Today | -0.030p |
| % Change | -1.51 % |
| 52 Week High | 4.80p |
| 52 Week Low | 1.51p |
| Volume | 231,086 |
| Shares Issued | 295.18m |
| Market Cap | £5.77m |
| RiskGrade | 353 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 13:45 | 8,000 @ 1.73p |
| 10:34 | 1,041 @ 2.40p |
| 09:05 | 222,045 @ 1.76p |
You are here: research